Teens' sleep habits may boost vaccine power
NCT ID NCT07636525
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether sleep habits of 11-12 year olds affect their immune response to the meningococcal vaccine (MCV4). About 66 healthy teens will wear a sleep tracker and keep their normal sleep schedule for 5 weeks. Researchers will measure antibody levels after vaccination to see if sleep quality matters.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- MCV4 meningococcal vaccine
- What this could lead to
- If it works, this could show that good sleep helps vaccines work better in teens, leading to stronger protection.
- What could go wrong
- This is a small pilot study, so results may not apply to all teens. It only looks at one vaccine and doesn't test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VACCINATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cincinnati Children's Hospital Medical Center
RECRUITINGCincinnati, Ohio, 45229, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hospital push could shield seniors from preventable diseases
- Meningitis b vaccine shows promise in children
- Simple exercise test may reveal hidden risks in flu patients
- Nutrient sachets may boost vaccination rates in rural africa
- Text reminders help get young kids vaccinated on time
- Mpox vaccine trial for infants: could a Half-Dose protect just as well?